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INTRODUCTION
Symptoms of benign prostatic hyperplasia (BPH) are called
lower urinary tract symptoms (LUTS) and are categorized as
voiding and storage symptoms. The voiding symptoms,
which include hesitancy and a weak stream, have been attri-
buted to a static component caused by the mass of the enlarged
gland and a dynamic component caused by the tone of the
smooth muscle of the prostatic stroma. Storage symptoms
such as frequent and urgent urination have been associated
with bladder dysfunction caused by bladder outlet obstruc-
tion (BOO) (1). 
Evidence of a link between BPH and voiding symptoms
is well established, but there is no direct evidence of a link
between BPH and storage symptoms. Although obstructions
can be relieved by prostatectomy or administration of alpha-
adrenergic blockers, up to 38% of men with BPH continue
to suffer from storage symptoms (2). Obstructed bladder
dysfunction caused by BPH is characterized by alterations
in bladder mass, tissue composition, capacity, compliance
and the response to pharmacological agents. Storage symp-
toms are displayed in the compensatory stage subsequent to
these changes (3). Many pathophysiological mechanisms have
been proposed, including changes in detrusor morphology
and innervation, intercellular communication and electrical
properties, detrusor receptors, ischemic/reperfusion injury,
increased synthesis and deposition of connective tissue, urothe-
lial mechanoafferent signaling, and central nervous system
regulation (4, 5). Recently, many scientists have become inter-
ested in the potential of molecular biology for identifying
pathophysiological mechanisms. It has been suggested that
hyperplasia and apoptosis of bladder muscle following BOO
are opposing cellular processes, which mediate the bladder’s
response to short-term obstructive stimuli, and that local
synthesis of growth-promoting and growth-inhibitory factors
may be responsible for initiating both of these responses (6).
Moreover, following obstruction of the bladders of animal
models and patients with BPH, there were acute increases in
the expression of bFGF (7), the transcription factors, upstream
binding factor, c-Jun, and cyclins E and C (8), nerve growth
factor (9), N-ras and c-myc (10), and decreased expression of
TGF-beta 1 (7). This suggests that these changes may play
a role in obstruction-induced bladder hypertrophy and dys-
function. Because these changes cannot explain all the patho-
physiological mechanisms of storage symptoms exhibited
following BOO, an alternative tool is needed.
Recent developments in proteomic technologies have pro-
vided tools for discovering and identifying disease-associated
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Investigation of Early Protein Changes in the Urinary Bladder Following
Partial Bladder Outlet Obstruction by Proteomic Approach
We investigated the pathophysiological mechanism by proteomic approach as a
possible tool to detect the marker proteins to develop lower urinary tract symptoms
following bladder outlet obstruction (BOO). Rats were randomized into 3 groups;
control, sham operation and BOO groups. BOO group was divided into 1, 3, and 5
day-group. Conventional proteomics was performed with high resolution 2-D gel
electrophoresis followed by computational image analysis and protein identification
using mass spectrometry using rat urinary bladders. A comparison of bladder of
BOO group with control bladder showed that three proteins of optineurin, thiore-
doxin and preprohaptoglobin were over-expressed in the bladder of BOO group.
In addition, four proteins, such as peroxiredoxin 2, transgelin, hippocampal cholin-
ergic neurostimulating peptide (HCNP) and beta-galactoside-binding lectin, were
under-expressed in the bladder of BOO group. These data supported that down-
regulation of HCNP might make detrusor muscle be supersensitive to acetylcholine,
up-regulation of optineurin means the protection of nerve injury, and down-regula-
tion of transgelin means the decreased contractility of detrusor muscle. Beside these
proteins, other proteins are related to oxidative stress or have a nonspecific func-
tion in this study. However more information is needed in human bladder tissue for
clinical usage.
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biomarkers. As data generated using proteomic technologies
reflect the impact on the cell of intrinsic genetic effects and
the environment, these methods are very useful for determin-
ing biomarkers. In humans, it is difficult to investigate the
cellular mechanisms that mediate obstructive bladder dys-
function. 
We investigated the proteomics of this disease using the
rat because many of the structural and functional changes
associated with human bladder pathology can be induced in
animal models of partial outlet obstruction (11). Although
application of these technologies to search for potential diag-
nostic/prognostic biomarkers associated with BOO has been
limited, this database will provide a more valuable resource
for identification of biomarkers than genomic methods.
MATERIALS AND METHODS
Procedures of partial bladder outlet obstruction 
Female Sprague-Dawley rats were obtained at 8 weeks of
age. The rats were housed in groups of three with hardwood
bedding in windowless animal rooms. Animal rooms were
illuminated according to a 12 hr light/dark cycle and were
maintained at a temperature of 22±1℃and a relative humi-
dity of 50±20%. After a quarantine period of 1 week, ani-
mals were randomized into three groups: a control group
(10 rats), a sham operation group (10 rats) and a BOO group
(30 rats). The BOO group was randomly sub-divided into
1-, 3-, and 5-day sub-groups of 10 rats each. Polyethylene
catheters (PE200, inner diameter 1.40 mm; Clay-Adams,
Parsippany, NJ, U.S.A.) were used to create partial BOO.
After establishing anesthesia with ketamine (100 mg/kg body
weight intramuscularly), the bladder and proximal urethra
were exposed through an incision in the lower abdomen. The
proximal urethra was freed from the vaginal wall by careful
dissection to avoid injury to the periurethral blood vessels.
The wall of a 2 mm wide transverse slice of catheter material
was cut to open the ring, which was placed around the prox-
imal urethra. The implanted catheters fitted loosely around
the urethra, resulting in a constant and mild degree of BOO.
The abdominal wound was closed and the animals received
150 mg/kg body weight ampicillin intramuscularly. No rats
died of urinary complications. Sham operated rats underwent
similar procedures but the implanted catheter was removed
before closing the abdominal wound. 1, 3 or 5 days follow-
ing the operation, urinary bladders were excised under anes-
thesia induced by intraperitoneal injection. Following this,
all rats were exsanguinated after cervical dislocation. The
bladders were placed in liquid nitrogen after weighing.
Procedures for protein extraction
Proteins were extracted from rat urinary bladder tissue
according to the German Heart Center method (http://user-
page.chemie.fu-berlin.de/~pleiss/tissue.html; accesssed on
December 2004). Bladder tissue was washed in buffer con-
taining 50 mM Tris-HCl (pH 7.1), 100 mM KCl, 60 mM
EDTA, 5.8 mM benzamidine and 0.2 mM PMSF and is lyo-
philized for 1 hr. Samples of 30 mg were crushed after immer-
sion in liquid nitrogen and were solublized in 100  L buffer
containing 7 M urea, 2 M thiourea, 4% CHAPS, 100 mM
DTT, 25 mM Tris-HCl (pH 7.1), 50 mM KCl, and 0.2%
Bio-Lyte 3/10 Ampholyte. DNase was added (210 U) and
the solution was then incubated at room temperature for 30
min. Insoluble material was removed by centrifugation at
14,737×g for 20 min at 10℃. Protein concentration was
determined using a commercial Bradford reagent (Bio-Rad
protein assay kit, Hercules, CA, U.S.A.), and the samples
were stored at -70℃until analysis.
Two-dimensional electrophoresis
The first-dimensional gel separation was carried out with
17cm pH 4-7 immobile pH gradient (IPG) strips following
the manufacturer’s protocol (Bio-Rad) with minor modifica-
tions. Samples containing up to 1 mg of protein were loaded
and isoelectric focusing (IEF) was performed using a PRO-
TEAN IEF cell for 145 kV hr at 20℃. After IEF, strips were
equilibrated for 15 min in 6 M urea, 2% SDS, 0.05 M Tris-
HCl (8.8) and 20% glycerol containing 2% DTT, and then
equilibrated again for 15 min in the same buffer containing
2.5% iodoacetamide. Equilibrated IPG strips were transferred
onto 15% uniform polyacrylamide gels and run in a PRO-
TEAN II Xi cell tank at 30 mA per gel. The gels were visual-
ized using Coomassie Brilliant Blue R250 staining. After stai-
ning, 2D gels were imaged using Powerlook 1100 (UMAX,
Fremont, CA, U.S.A.). The images were analyzed using Mela-
nie III (Swiss Institute of Bioinformatics, Geneva, Switzer-
land). All samples were processed at least three times to con-
firm reproducibility.
Protein identification 
Proteins that are differentially expressed in the bladder
tissue are identified by matrix assisted laser desorption/ion-
ization-the time of flight mass spectrometry (MALDI-TOF
MS) analysis (Yonsei Proteome Research Center, Seoul, Korea)
with the search programs called ProFound and MS-FIT.
RESULTS
The mean bladder masses of the control and sham-operat-
ed rats were 122±15 mg and 131±19 mg, respectively.
Mean bladder mass of the obstructed rats was 275±68 mg
at 24 hr and increased to 467±212 mg by 120 hr. The con-
trol group did not exhibit any pathological lesions of the uri-1002 H.-J. Kim, I. Sohng, D.-H. Kim, et al.
nary bladder. The urinary bladders of the obstructed rats were
generally thickened.
Two-dimensional electrophoresis of bladder tissue produced
about 1,000 spots per gel. Electrophoretic images of samples
taken from normal and sham-operated bladder tissue were
depicted in Fig. 1, 2, which show that there were no signifi-
Fig. 1. Two-dimension electrophoresis pattern of rat normal blad-
der tissue. Expressed number indicated proteins to be up-regu-
lated or down-regulated at post-operative study (4; peroxiredoxin,
5; hippocampal cholinergic neurostimulating peptide, 6; optineurin,
7; transgelin, 9; beta-galactoside-binding lectin, 10; thioredoxoin,
12; albumin).
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Fig. 2. Two-dimension electrophoresis pattern of rat bladder tissue
of sham-operated group. There is no difference from control group
(4; peroxiredoxin, 5; hippocampal cholinergic neurostimulating
peptide, 6; optineurin, 7; transgelin, 9; beta-galactoside-binding
lectin, 10; thioredoxoin, 12; albumin).
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Fig. 3. Two-dimension electrophoresis pattern of rat bladder tissue
of obstructed group (post-operative 1 day). Electrophoretic images
of up-regulated and down-regulated proteins were shown. Num-
ber 1, 2, and 3 were prehaptoglobins and increased transiently
at 24 hr. (4; peroxiredoxin, 5; hippocampal cholinergic neurostimu-
lating peptide, 6; optineurin, 7; transgelin, 9; beta-galactoside-
binding lectin, 10; thioredoxoin, 12; albumin).
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Fig. 4. Two-dimension electrophoresis pattern of rat bladder tissue
of obstructed group (post-operative 5 day). Electrophoretic images
of up-regulated and down-regulated proteins were shown. (4; per-
oxiredoxin, 5; hippocampal cholinergic neurostimulating peptide,
6; optineurin, 7; transgelin, 9; beta-galactoside-binding lectin, 10;
thioredoxoin, 12; albumin).
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cant differences between these groups. The proteins shown
in these figures were not all identified because, for many, the
expression in obstructed bladder tissue was similar to that
in normal bladder tissue. Electrophoretic images of up-reg-
ulated and down-regulated proteins are shown in Fig. 3, 4.
A comparison of images of proteins from bladders of obstruct-
ed rats with those of the controls showed that three proteins,
optineurin (OPTN), thioredoxin and preprohaptoglobin,
were over-expressed in the bladders of obstructed rats. Of
these, thioredoxin and preprohaptoglobin increased transiently
at 24 hr. Four proteins (peroxiredoxin 2, transgelin [SM22
alpha], hippocampal cholinergic neurostimulating peptide
[HCNP] and beta-galactoside-binding lectin) were under-
expressed in the obstructed bladder. Beta-galactoside-bind-
ing lectin was shown to be decreased transiently at 24 hr.
Of the changes in protein expression detected in this proteomic
analysis, the over-expression of OPTN and the under-expres-
sion of transgelin and HCNP were most noteworthy (Fig. 5)
(Table 1, 2).
DISCUSSION
LUTS such as frequent or urgent urination may occur in
BPH patients with bladder outlet obstruction. The exact
causes and mechanisms of LUTS are unknown, although
many theories have been proposed. We investigated a possi-
ble mechanism of LUTS in BOO using a proteomic approach.
When the human genome project is completed, the practice
of medicine will be altered fundamentally. Proteomic meth-
*The ‘‘Z score’’ is estimated when the search result is compared against
an estimated random match population. For instance, a Z score of 1.65
for a search means that the search is in the 95th percentile. Conceptu-
ally, this ‘‘95th percentile’’ is different from ‘‘95% confidence’’ that the
search is a correct identification. (http://129.85.19.192/profound/help.
html#ZSCORE)
Accession
No.
Calculated
pI/Mw (kDa) 
Apparent
pI/Mw (kDa)
Protein 
identified
Estimated
NP_659549 5.2/67.20 4.65/33 optineurin 1.03
NP_446252 4.8/12.00 4.9/15 thioredoxin 2.40
AAA_41349 7.2/30.43 5.37/40 preprohap- 2.25
toglobin
Table 1. Up-regulated proteins in hyperplastic bladder tissue
*The ‘‘Z score’’ is estimated when the search result is compared against
an estimated random match population. For instance, a Z score of 1.65
for a search means that the search is in the 95th percentile. Conceptu-
ally, this ‘‘95th percentile’’ is different from ‘‘95% confidence’’ that the
search is a correct identification. (http://129.85.19.192/profound/help.
html#ZSCORE)
Accession
No.
Calculated
pI/Mw (kDa) 
Apparent
pI/Mw (kDa)
Protein 
identified
Estimated
NP_058932 5.5/20.90 5.56/24 hippocampal 1.40
cholinergic
neurostimulating 
peptide
NP_113737 8.9/22.64 6.43/20 transgelin 2.17
NP_058885 5.3/21.94 5.44/25 peroxiredoxin 2 2.36
NP_063969 5.1/15.18 4.97/15 beta-galactoside 2.39
binding-lectin 
Table 2. Down-regulated proteins in hyperplastic bladder tissue
Fig. 5. 2-DE patterns showing the up- or down-regulation of important proteins in obstructed bladder tissues as compared to normal tissues.
a: normal, b: sham-operative group, c: post-operative 1 day, d: post-operative 3 day, e: post-operative 5 day. (A) 2-DE patterns showing
the up-regulation of optineurin (arrow) in bladder hyperplastic tissues as compared to normal tissues. (B) 2-DE patterns showing the down-
regulation of transgelin (arrow) in bladder hyperplastic tissues. (C) 2-DE patterns showing the down-regulation of hippocampal choliner-
gic neurostinulatind peptide (arrow) in bladder hyperplastic tissues.
a b
a b c d e
a b c d e
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B
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ods detect the functional units of expressed genes using pro-
tein fingerprinting (12, 13). At present, it is commonly held
that proteins are the main functional outputs of genes and
that proteomics will lead biology and medicine beyond geno-
mics. The identification, quantification, classification, and
functional assignment of proteins will be essential for a full
understanding of these molecular events. Such information
will likely prove to be crucial for amelioration of bladder
changes incurred following partial BOO (14, 15).
In this study, we detected the over-expression of three pro-
teins (OPTN, thioredoxin and preprohaptoglobin), and the
under-expression of four proteins (peroxiredoxin 2, transgelin
[SM22 alpha], HCNP, and beta-galactoside-binding lectin).
Of these HCNP, OPTN and transgelin were of particular
interest. HCNP was originally purified from the hippocam-
pus of the young rat, and is associated with memory and learn-
ing (16). HCNP or its precursor, or both, may have a func-
tion in the peripheral as well as in the central nervous sys-
tem (16). HCNP has been detected in variety of tissues and
organs, such as the salivary gland, bronchiole, adrenal gland,
small intestine and testis. It has been shown that HCNP-
immunopositive nerve cell bodies and nerve fibers are pre-
sent in the submucosal and myenteric plexuses of the small
intestine of the rat (17). Human and rat HCNP are 54.5%
homologous, and both stimulate acetylcholine synthesis (18).
It has been shown that mutations in the OPTN gene are the
principal cause of adult-onset primary open angle glaucoma.
The existing evidence suggests that the direct interaction of
OPTN with the E3-14.7K protein probably uses TNF-alpha
or Fas-ligand pathways to mediate apoptosis, inflammation,
or vasoconstriction (19). OPTN may play a neuroprotective
role in the eye and optic nerve (20). Transgelin is an actin
cross-linking/gelling protein found in fibroblasts and smooth
muscle and is sensitive to transformation and shape-changes
(21). Its expression is down-regulated in many cell lines, and
this property may be an early and sensitive marker for the
onset of transformation (22). Ablation of transgelin decreases
the contractility and actin content of mouse vascular smooth
muscle. Thus, transgelin plays a role in contractility, possi-
bly by affecting actin filament organization (23). Beside these
proteins, other proteins are related to oxidative stress or have
a nonspecific function. Thioredoxin (Trx) is small globular
proteins that proved to be excellent model for investigating
the relationship between the structure of protein and their
physico-chemical and functional properties (24) and has a
role as an antioxidant (25). Plasma/serum levels of Trx 1 are
good markers for oxidative stress. Exogenous Trx 1 shows
cytoprotective and anti-inflammatory effects and has a good
potential for clinical application (25). Preprohaptoglobin has
a function protecting the tissues from oxidative damage (26).
In this study thioredoxin and preprohaptoglobin increased
transiently at 24 hr. This suggests that BOO induced hypox-
ia/reperfusion injury, but this finding needs to more experi-
ments and information about that. Peroxiredoxins are nuclear
encoded thiol-proteins with molecular masses of 17 to 24
kDa. They are ubiquitious peroxidases reducing a broad spec-
trum of peroxides like H2O2, lipid hydroperoxide and perox-
initrite, and related to oxidative stress (27). Beta-galactoside-
binding lectin (galectin) has recently been designated as ga-
lectins and has related to variable pathogenesis; immunity,
carcinogenesis, neural pain, etc (28-30). In this study the
function of galectin remains unknown to the development
of BOO symptoms. 
In conclusion, bladder outlet obstruction resulted in an
increase in the expression of three proteins and a decrease in
the expression of four proteins in our rat model system. Of
these proteins, HCNP, OPTN, and transgelin are of partic-
ular interest. Up-regulation of OPTN may protect against
nerve injury. Down-regulation of HCNP may make detru-
sor muscle supersensitive to acetylcholine and down-regula-
tion of transgelin may decrease its contractility. Beside these
proteins, other proteins are related to oxidative stress or have
a nonspecific function in this study. So proteins of urinary
bladder changed by BOO seem to be responsible to the dam-
age for bladder function in this animal study. However, more
information on human bladder tissue and other urodynamic
study are needed before clinical application of these findings
is warranted.
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